• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DAVOL INC., SUB. C.R. BARD, INC. -1213643 VENTRALEX ST; SURGICAL MESH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DAVOL INC., SUB. C.R. BARD, INC. -1213643 VENTRALEX ST; SURGICAL MESH Back to Search Results
Catalog Number 5950009
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Wound Dehiscence (1154); Cellulitis (1768); Unspecified Infection (1930)
Event Date 02/26/2018
Event Type  Injury  
Event Description
Reported per clinical trial (b)(6): on (b)(6) 2016: subject patient underwent an open technique procedure for primary right upper quadrant incisional hernia repair using a small bard/davol ventralex st mesh, primary left upper quadrant incisional hernia repair using a medium ventralex st mesh and incisional hernia repair using a large ventralex st mesh, which were fixated using sutures full skin closure was achieved using staples and sutures.The patient was discharged from the hospital on (b)(6) 2016.On (b)(6) 2018: patient presented to emergency department with fever, chills, weakness and redness of abdomen.Patient admitted and diagnosed with cellulitis secondary to infected mesh.Ct imaging showed infection of the mesh.Wound dehiscence was noted, the mesh (large ventralex st mesh) was intact.Patient was diagnosed with a superficial incisional surgical site infection (ssi) and treated with intravenous antibiotics.The patient was discharged from hospital on (b)(6) 2018.As reported, the subject was implanted with a non-study mesh in addition to study mesh at the index procedure and it cannot be determined which mesh caused the infection.Per the study clinician, the reported adverse event (mesh infection, wound dehiscence) has been assessed as moderate in severity, possibly related to the large ventralex st mesh and indeterminate to the index procedure.The outcome for this ae is reported as recovered/resolved.The reported adverse event (cellulitis) has been assessed as moderate in severity, possibly related to the large ventralex st mesh and definitely related to the index procedure.The outcome for this ae is reported as recovering/resolving.
 
Manufacturer Narrative
As reported, about 1.3 years post-implant of the large ventralex st mesh, the patient was diagnosed with mesh infection (ssi), wound dehiscence and cellulitis of the trunk and was treated with intravenous antibiotics.As reported, the ae of mesh infection is recovered/resolved and the ae of cellulitis is resolving.The clinician has assessed the patient¿s postoperative course of mesh infection and cellulitis as being moderate, and possibly related to the study device, however, based on the information provided no conclusion can be made.Review of manufacturing records confirms product was manufactured to specification.To date, this is the only reported complaint from this manufacturing lot of 189 units released for distribution in september, 2016.Infection is a known inherent risk of surgery.The adverse reactions section of the instructions-for-use, supplied with the device lists infection as a possible complication.In regards to the infection, the warnings section of the ifu states "if an infection develops, treat the infection aggressively.Consideration should be given regarding the need to remove the prosthesis.An unresolved infection may require removal of the prosthesis." this mdr represents the large ventralex st mesh.Two additional mdrs were submitted to represent the small ventralex st mesh and medium ventralex st mesh.Not returned - remains implanted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENTRALEX ST
Type of Device
SURGICAL MESH
Manufacturer (Section D)
DAVOL INC., SUB. C.R. BARD, INC. -1213643
100 crossings blvd.
warwick RI 02886
Manufacturer (Section G)
BARD SHANNON LIMITED -3005636544
san geronimo industrial park
lot #1, road #3, km 79.7
humacao PR 00791
Manufacturer Contact
andrew topoulos
100 crossings blvd.
warwick, RI 02886
8005566756
MDR Report Key14495194
MDR Text Key292586530
Report Number1213643-2022-00329
Device Sequence Number1
Product Code FTL
UDI-Device Identifier00801741031496
UDI-Public(01)00801741031496
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K101928
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Study,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 05/17/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/28/2018
Device Catalogue Number5950009
Device Lot NumberHUAU1600
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/28/2022
Initial Date FDA Received05/25/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/14/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age48 YR
Patient SexFemale
Patient Weight115 KG
-
-